{
    "Trade/Device Name(s)": [
        "PocguideTM Multi-Drug Test Cup OTC",
        "PocguideTM Multi-Drug Test Cup"
    ],
    "Submitter Information": "Aicheck Biotech, Inc.",
    "510(k) Number": "K242077",
    "Predicate Device Reference 510(k) Number(s)": [
        "K182701"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NFT",
        "PTH",
        "NGL",
        "NFV",
        "NFY",
        "PTG",
        "NGG",
        "NGM",
        "NGM",
        "QAW",
        "NFW"
    ],
    "Summary Letter Date": "July 12, 2024",
    "Summary Letter Received Date": "July 16, 2024",
    "Submission Date": "July 11, 2024",
    "Regulation Number(s)": [
        "21 CFR 862.3100",
        "21 CFR 862.3150",
        "21 CFR 862.3650",
        "21 CFR 862.3170",
        "21 CFR 862.3250",
        "21 CFR 862.3620",
        "21 CFR 862.3610",
        "21 CFR 862.3910",
        "21 CFR 862.3870"
    ],
    "Regulation Name(s)": [
        "Amphetamine Test System",
        "Barbiturate Test System",
        "Opiate Test System",
        "Benzodiazepine Test System",
        "Cocaine and cocainemetabolite test system",
        "Methadone Test System",
        "Methamphetamine Test System",
        "Tricyclic antidepressant drugs test system",
        "Cannabinoids Test System"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Amphetamine (AMP)",
        "Buprenorphine (BUP)",
        "Secobarbital (BAR)",
        "Oxazepam (BZO)",
        "Benzoylecgonine (COC)",
        "2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP)",
        "Methamphetamine (MET)",
        "Methylenedioxymethamphetamine (MDMA)",
        "Morphine (OPI2000/MOP300)",
        "Methadone (MTD)",
        "Oxycodone (OXY)",
        "Phencyclidine (PCP)",
        "Nortriptyline (TCA)",
        "Marijuana (THC)"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [
        "Cup"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Competitive binding",
        "Lateral flow immunochromatographic assay",
        "Antigen-antibody reaction"
    ],
    "Methodologies": [
        "Immunochromatographic assay",
        "Lateral flow"
    ],
    "Submission Type(s)": [
        "Assay",
        "Cup",
        "Point-of-care",
        "Specimen collection device"
    ],
    "Document Summary": "FDA 510(k) summary for PocguideTM Multi-Drug Test Cup (OTC), a lateral flow immunochromatographic urine test for multiple drugs of abuse screening.",
    "Indications for Use Summary": "For qualitative and simultaneous detection of multiple drugs of abuse (amphetamine, buprenorphine, secobarbital, oxazepam, cocaine, EDDP, methamphetamine, MDMA, morphine, methadone, oxycodone, phencyclidine, nortriptyline, marijuana) in human urine, for over-the-counter use.",
    "fda_folder": "Toxicology"
}